BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit
BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA venture.
63 articles, transcripts, and reports
BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA venture.
Pfizer inc (NYSE: PFE) FY 2026 Other Release
Pfizer inc (NYSE: PFE) Sec Form 10K
Pfizer inc (NYSE: PFE) FY 2026 Other Release
Pfizer inc (NYSE: PFE) FY 2026 Other Release
Pfizer inc (NYSE: PFE) FY 2026 Corporate Conference
Pfizer inc (NYSE: PFE) FY 2026 Other Release
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2025 earnings results today. Revenues dipped 1% year-over-year to $17.6 billion. On an operational basis, revenues were…
Pfizer inc (NYSE: PFE) Q2 2025 Earnings Call dated Aug. 05, 2025 Corporate Participants: Francesca DeMartino — Chief Investor Relations Officer, Senior Vice President Albert…
Pfizer inc (NYSE: PFE) Q3 2025 Earnings Call dated Nov. 04, 2025 Corporate Participants: Francesca DeMartino — Chief Investor Relations Officer and Senior Vice President…